Clinical Trials in Salt Lake City

Showing 2601-2620 of 14,325 trials

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

NCT03169881

Study Hypothesis: Preterm infants administered weekly Darbe during the neonatal period will have improved neurocognitive outcome at 22-26 months compared to placebo

NeurocognitiveNeuroprotectiveNeonatal+1 more

NICHD Neonatal Research Network650 participantsStarted Sep 2017

Birmingham, Alabama, United States • Palo Alto, California, United States • Atlanta, Georgia, United States +13 more locations

RECRUITINGPhase 1/2< 1 mile

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

NCT05643742

This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112™ in subjects with relapsed or refractory B-cell malignancies.

B-cell LymphomaNon-Hodgkin LymphomaB-cell Malignancy+5 more

CRISPR Therapeutics AG120 participantsStarted Mar 2023

Westwood, Kansas, United States • St Louis, Missouri, United States • San Antonio, Texas, United States +4 more locations

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Find Trials by Condition in Salt Lake City

A Study to Assess Growth in Children With Idiopathic Short Stature

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study

A Study of PF-06873600 in People With Cancer

12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks

A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Delirium in Children Undergoing Stem Cell Transplantation

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism